Background: To date, autologous punch grafting appears to be the easiest and least expensive surgical technique for stable vitiligo and piebaldism. Punch grafting is available worldwide, with no need for specialised instruments. However, no reliable data on efficacy and safety of different punch depths and punch sizes are available.
Objective/methods: To compare the efficacy and safety of different punch depths and punch sizes in autologous punch grafting, a randomised controlled trial was performed in 33 patients with vitiligo or piebaldism. In each patient, four depigmented regions were allocated to: 1.5 mm deep grafts, 1.5 mm superficial grafts, 1.0 mm deep grafts, and 1.0 mm superficial grafts. Primary outcome was the total pigmented surface area. Secondary outcomes were Patients' Global Assessment (PGA) and side effects.
Results: Six months after grafting, 1.5 mm grafts showed a significantly larger pigmented surface area compared to 1.0-mm grafts (p < 0.001), though more side effects as well. No significant differences in the total pigmented surface between different punch depths were found. Deep grafts showed more erythema compared to superficial grafts.
Conclusion: We recommend 1.5 mm superficial grafts in autologous punch grafting for trunk and proximal extremities in patients with stable vitiligo and piebaldism.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/09546634.2016.1179251 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Sustained Repigmentation in Vitiligo and Leukodermas Using Melanocyte-Keratinocyte Transplantation: 7 Years of Data.
Clin Cosmet Investig Dermatol
November 2024
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Background: The autologous non-cultured melanocyte-keratinocyte transplantation procedure (MKTP) has emerged as an effective treatment for various types of vitiligo and leukodermas. However, there is limited data on the long-term outcomes of the MKTP, especially in Thai patients.
Objective: To assess the long-term efficacy and safety of the MKTP in patients with vitiligo and other leukodermas.
Comparative outcomes of autologous cultured melanocytes transplantation and non-cultured epidermal cell suspension transplantation in piebaldism patients: A retrospective study.
Skin Res Technol
January 2024
Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, PR China.
Purpose: To compare the efficacy and safety of autologous cultured melanocytes transplantation (CMT) and non-cultured epidermal cell suspension transplantation (NCES) in the treatment of piebaldism.
Patients And Methods: A retrospective study was conducted on 30 anatomically based lesions from nine piebaldism patients who underwent either CMT (n = 7) or NCES (n = 23) between 2018 and 2020. The extent of repigmentation and colour matching was evaluated in all recipient sites using a digital imaging analysis system.
Lesional CD8+ T-Cell Number Predicts Surgical Outcomes of Melanocyte-Keratinocyte Transplantation Surgery for Vitiligo.
J Invest Dermatol
November 2023
Department of Dermatology, UMass Chan Medical School, Worcester, Massachusetts, USA. Electronic address:
Article Synopsis
- * A study analyzed the immunological profiles of stable vitiligo patients undergoing MKTP, focusing on T-cell subsets and melanocyte quantification, to understand factors affecting post-surgery outcomes.
- * Results showed that higher CD8+ T-cell levels in vitiligo lesions were linked to poorer repigmentation outcomes after MKTP, suggesting that this T-cell count could help identify better candidates for the procedure.
Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review.
Dermatology
October 2023
Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA.
Article Synopsis
- The autologous noncultured melanocyte keratinocyte transplant procedure (MKTP) is an effective method for repigmentation in patients with vitiligo, but the best recipient-to-donor (RD) ratio for optimal results is still unknown.
- A study involving 120 patients found that those with focal/segmental vitiligo (SV) showed higher repigmentation rates (80.2% mean improvement) compared to those with non-segmental vitiligo (58.3%) and leukoderma/piebaldism (51.8%), with a notable finding that non-white patients had a higher RD ratio.
- The results indicate that while lower RD ratios were associated with better outcomes, the type
Meek micrografting, a novel surgical technique for the treatment of vitiligo and piebaldism: A case series.
J Eur Acad Dermatol Venereol
April 2023
Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!